For our sixth annual Cancer Health 25, we salute patient advocates for their unwavering efforts to support the cancer community. To be clear, our Cancer Health 25 is not a “best of” list or a “most ...

Colon and rectal cancer: The USPSTF recommends colorectal cancer screening for adults ages 45 to 75 at average risk. People at increased risk may benefit from earlier screening. Options include a ...

Combining standard adjuvant chemotherapy with the immune checkpoint inhibitor atezolizumab [Tecentriq] leads to a significant improvement in disease-free survival in a subset of patients with Stage ...

As their first-line treatment, people with HR-positive, HER2-negative advanced breast cancer often receive hormone therapy—most commonly an aromatase inhibitor—given in combination with a CDK4/6 ...

Overall, people who used GLP-1 agonists had a 7% lower risk of developing obesity-related cancers than those who used DPP-4 inhibitors. The effect was more pronounced for women, who had an 8% lower ...

SCLC accounts for around 15% of lung cancer cases. It is the most aggressive type of lung cancer, and about 70% of patients are diagnosed after it has already spread. Prognosis is generally poor, and ...

Strategic Philanthropy in Action By joining forces, we are paving the path to cures, by identifying the biggest opportunities where we can truly stimulate innovation and make significant advances in ...

Many men will have options for fathering children after cancer treatment. These may include banking sperm and freezing testicular tissue prior to treatment. Saving testicular tissue can potentially ...

My PSA was 3.95 ng/mL, and my internist was growing jittery. So he referred me to a urologist, who conducted a needle biopsy during which he poked my anesthetized prostate 14 times to remove tiny ...

I found an oncologist at the Mayo Clinic [in Rochester, Minnesota] who specializes in CLL. Initial blood tests suggested a less than 20% chance that I would need treatment in the next five years and ...

In 1957, E. Donnall Thomas, MD, who would later become Fred Hutch’s first medical oncology director, published a landmark study in the New England Journal of Medicine about six patients with end-stage ...

Wright and colleagues combined the data from two clinical trials to evaluate outcomes in patients with DCIS treated with or without radiotherapy. In NRG/RTOG 9804, patients with “good-risk” DCIS were ...